Elevance Health
ELV
#116
Rank
$127.29 B
Marketcap
$547.71
Share price
0.70%
Change (1 day)
19.63%
Change (1 year)

P/E ratio for Elevance Health (ELV)

P/E ratio as of May 2024 (TTM): 21.3

According to Elevance Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 21.3011. At the end of 2022 the company had a P/E ratio of 20.6.

P/E ratio history for Elevance Health from 2002 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202220.611.3%
202118.54.83%
202017.710.03%
201916.1-11.07%
201818.118.42%
201715.2-0.4%
201615.36.74%
201514.36.96%
201413.420.97%
201311.151.06%
20127.34-18.34%
20118.9912.09%
20108.0237.28%
20095.84-33.61%
20088.80-43.46%
200715.6-2.55%
200616.0-19.18%
200519.8-10.35%
200422.064.2%
200313.4-2.31%
200213.7

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.